Showing results (31-40 of 643) with videos related to
Sort By:
Pageof 65
Expert Opinion on Therapeutic Targets|May 30, 2024
New targets and mechanisms of action for lipid-lowering and anti-inflammatory therapies in atherosclerosis: where does the field stand?Stephen J Nicholls, Adam J NelsonThe Medical Journal of Australia|July 8, 2009
Medical education: revolution, devolution and evolution in curriculum philosophy and designGary A Wittert, Adam J NelsonCurrent Atherosclerosis Reports|November 21, 2022
CETP Inhibitors: Should We Continue to Pursue This Pathway?Stephen J Nicholls, Adam J NelsonAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 26, 2019
Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS TrialStephen J Nicholls, Adam J NelsonAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 6, 2019
Do Cholesteryl Ester Transfer Protein Inhibitors Have a Role in the Treatment of Cardiovascular Disease?Stephen J Nicholls, Adam J NelsonCurrent Atherosclerosis Reports|February 15, 2025
Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering TherapyStephen J Nicholls, Adam J NelsonEuropean Cardiology|May 11, 2026
The Impact of Current and Emerging Therapies on Lipoprotein(a)Stephen J Nicholls, Adam J NelsonPageof 65